大塚ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/09/17 | 4,461 | 4,484 | 4,449 | 4,476 | +27 | +0.6% | 441,300 |
2020/09/16 | 4,490 | 4,493 | 4,440 | 4,449 | -70 | -1.5% | 847,200 |
2020/09/15 | 4,565 | 4,571 | 4,497 | 4,519 | -67 | -1.5% | 685,700 |
2020/09/14 | 4,564 | 4,610 | 4,547 | 4,586 | +47 | +1% | 533,900 |
2020/09/11 | 4,532 | 4,545 | 4,415 | 4,539 | +24 | +0.5% | 1,107,700 |
2020/09/10 | 4,498 | 4,519 | 4,479 | 4,515 | +62 | +1.4% | 716,800 |
2020/09/09 | 4,433 | 4,467 | 4,412 | 4,453 | -60 | -1.3% | 806,300 |
2020/09/08 | 4,477 | 4,513 | 4,444 | 4,513 | +59 | +1.3% | 578,100 |
2020/09/07 | 4,416 | 4,474 | 4,414 | 4,454 | +44 | +1% | 573,300 |
2020/09/04 | 4,517 | 4,520 | 4,398 | 4,410 | -200 | -4.3% | 1,435,700 |
2020/09/03 | 4,624 | 4,643 | 4,603 | 4,610 | -36 | -0.8% | 641,700 |
2020/09/02 | 4,671 | 4,690 | 4,624 | 4,646 | +22 | +0.5% | 411,500 |
2020/09/01 | 4,645 | 4,665 | 4,603 | 4,624 | -33 | -0.7% | 682,700 |
2020/08/31 | 4,650 | 4,699 | 4,625 | 4,657 | +37 | +0.8% | 648,100 |
2020/08/28 | 4,692 | 4,731 | 4,553 | 4,620 | -29 | -0.6% | 893,700 |
2020/08/27 | 4,700 | 4,720 | 4,640 | 4,649 | -11 | -0.2% | 368,900 |
2020/08/26 | 4,610 | 4,676 | 4,600 | 4,660 | +2 | ±0% | 645,000 |
2020/08/25 | 4,683 | 4,711 | 4,655 | 4,658 | +6 | +0.1% | 734,300 |
2020/08/24 | 4,651 | 4,671 | 4,614 | 4,652 | -21 | -0.4% | 430,300 |
2020/08/21 | 4,683 | 4,725 | 4,662 | 4,673 | +54 | +1.2% | 464,400 |
2020/08/20 | 4,679 | 4,685 | 4,610 | 4,619 | -116 | -2.4% | 870,500 |
2020/08/19 | 4,730 | 4,766 | 4,728 | 4,735 | +6 | +0.1% | 425,600 |
2020/08/18 | 4,728 | 4,756 | 4,703 | 4,729 | +2 | ±0% | 636,000 |
2020/08/17 | 4,777 | 4,784 | 4,727 | 4,727 | -59 | -1.2% | 434,900 |
2020/08/14 | 4,802 | 4,812 | 4,764 | 4,786 | +17 | +0.4% | 720,100 |
2020/08/13 | 4,796 | 4,799 | 4,738 | 4,769 | +29 | +0.6% | 1,000,200 |
2020/08/12 | 4,775 | 4,780 | 4,692 | 4,740 | -32 | -0.7% | 1,124,400 |
2020/08/11 | 4,652 | 4,822 | 4,631 | 4,772 | +173 | +3.8% | 1,460,100 |
2020/08/07 | 4,569 | 4,624 | 4,446 | 4,599 | +90 | +2% | 1,266,400 |
2020/08/06 | 4,518 | 4,528 | 4,491 | 4,509 | -30 | -0.7% | 548,500 |
2020/08/05 | 4,570 | 4,571 | 4,490 | 4,539 | -8 | -0.2% | 471,600 |
2020/08/04 | 4,478 | 4,568 | 4,478 | 4,547 | +91 | +2% | 594,100 |
2020/08/03 | 4,408 | 4,460 | 4,380 | 4,456 | +86 | +2% | 846,000 |
2020/07/31 | 4,478 | 4,512 | 4,369 | 4,370 | -107 | -2.4% | 1,125,400 |
2020/07/30 | 4,517 | 4,536 | 4,472 | 4,477 | -37 | -0.8% | 3,996,700 |
2020/07/29 | 4,510 | 4,530 | 4,474 | 4,514 | -7 | -0.2% | 918,100 |
2020/07/28 | 4,538 | 4,577 | 4,510 | 4,521 | +13 | +0.3% | 959,000 |
2020/07/27 | 4,450 | 4,529 | 4,441 | 4,508 | +1 | ±0% | 1,137,300 |
2020/07/22 | 4,517 | 4,528 | 4,490 | 4,507 | -27 | -0.6% | 848,700 |
2020/07/21 | 4,557 | 4,587 | 4,534 | 4,534 | -49 | -1.1% | 851,200 |
2020/07/20 | 4,531 | 4,590 | 4,513 | 4,583 | +50 | +1.1% | 602,400 |
2020/07/17 | 4,540 | 4,553 | 4,505 | 4,533 | +34 | +0.8% | 596,400 |
2020/07/16 | 4,521 | 4,541 | 4,456 | 4,499 | -92 | -2% | 1,323,300 |
2020/07/15 | 4,563 | 4,617 | 4,544 | 4,591 | +41 | +0.9% | 774,500 |
2020/07/14 | 4,556 | 4,620 | 4,540 | 4,550 | -41 | -0.9% | 824,500 |
2020/07/13 | 4,550 | 4,597 | 4,495 | 4,591 | +145 | +3.3% | 837,000 |
2020/07/10 | 4,515 | 4,543 | 4,440 | 4,446 | -54 | -1.2% | 1,249,300 |
2020/07/09 | 4,509 | 4,536 | 4,460 | 4,500 | -79 | -1.7% | 1,311,800 |
2020/07/08 | 4,533 | 4,634 | 4,516 | 4,579 | +72 | +1.6% | 1,804,200 |
2020/07/07 | 4,582 | 4,587 | 4,482 | 4,507 | -126 | -2.7% | 1,560,400 |
1151~
1200
件表示中 / 3538件
類似銘柄と比較する
現在ご覧いただいている「大塚HD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大塚HD | 698,200円 | +2.2% | +10.2% | 1.72% | 13.41倍 | 1.35倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
第一三共 | 372,000円 | +6.0% | +4.0% | 2.10% | 23.09倍 | 4.27倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
武 田 | 427,500円 | -1.1% | +75.3% | 4.68% | 29.28倍 | 0.97倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
アステラス薬 | 141,900円 | +0.9% | +380.2% | 5.50% | 19.55倍 | 1.68倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 241,700円 | +20.9% | +10.6% | 2.73% | 11.43倍 | 1.51倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム